HomeNX1 • ASX
add
Nexalis Therapeutics Ltd
Previous close
$0.017
Day range
$0.018 - $0.018
Year range
$0.017 - $0.029
Market cap
3.87M AUD
Avg Volume
65.82K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
MarketWatch
13 hours ago
Nvidia’s stock extends its hot streak — and that’s great news for the S&P 500
2.61%
0.11%
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 214.66K | 55.11% |
Operating expense | 559.06K | 27.95% |
Net income | -382.22K | -62.03% |
Net profit margin | -178.06 | -4.46% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 436.90K | 124.15% |
Total assets | 1.43M | 101.10% |
Total liabilities | 2.38M | 206.96% |
Total equity | -950.52K | — |
Shares outstanding | 239.36M | — |
Price to book | ∞ | — |
Return on assets | -60.10% | — |
Return on capital | 411.48% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -382.22K | -62.03% |
Cash from operations | -463.54K | -178.93% |
Cash from investing | — | — |
Cash from financing | 441.33K | 353.46% |
Net change in cash | -22.21K | 67.75% |
Free cash flow | -110.61K | -14.56% |
About
Founded
2016
Website
